Viking Therapeutics, Inc. (VKTX)

38.47 +8.36 (+27.76%) USD  |  NASDAQ  |  Sep 22, 10:16
More

Viking Therapeutics CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for VKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical CAPEX To Revenue (TTM) Data

View and export this data back to . Start Trial.
Date Value

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Eli Lilly & Co. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Xencor, Inc. Upgrade